Researcher

Lisa F.P. Ng obtained her PhD in molecular virology in coronaviruses from the National University of Singapore (NUS) in 2002. After joining A*STAR’s Genome Institute of Singapore (GIS) in 2002 as a Postdoctoral Fellow, she worked on viral diseases such as hepatitis, severe acute respiratory syndrome and influenza. Ng is currently the Executive Director at A*STAR Infectious Diseases Labs (ID Labs) where she focuses on the immune responses to arthritic arboviruses that are epidemic or highly endemic in the tropical region. Ng has won numerous accolades for her research, including the ASEAN ‘International Young Scientist and Technologist Award’ in 2008 and A*STAR’s ‘Most Inspiring Mentor Award’ in March 2013.
Related Articles
What’s behind the rise of mpox?
12 Jul 2023Scientists survey how the mpox virus spreads through populations, the immunology of infections and current
Spotting the mechanisms of COVID-19 organ damage
4 Jul 2023A novel tissue-profiling approach provides new insights into the mechanisms of fatal COVID-19 by analysing
Breakthrough infections from a memory lapse
22 Mar 2023Vaccinated people affected by COVID-19 variants have different memory B cell responses than their close
How variants have loosened their grip
2 Dec 2022A deletion in the genome of SARS-CoV-2 variants makes resulting infections milder and could also
Why remdesivir works for some COVID-19 patients but not others
23 Jun 2022Remdesivir treatment is more likely to be successful in COVID-19 patients who are naturally able
A COVID-19 test as good as gold
3 Jun 2022A*STAR researchers create a next-generation, ultrasensitive COVID-19 rapid test powered by gold nanoparticles.